| Name | l-noradrenaline bitartrate |
|---|---|
| Synonyms |
(–)-Norinhrine (bittrate hydrate)
Adrenaline Ttrate Impurity B as Ttrate Monohydrate Noradrenaline Ttrate Monohydrate L-(-)-Noradrenaline monohydrate (+)-bittrate salt MFCD00150449 Noradrenaline Acid Ttrate / Norinhrine Acid Ttrate Noradrenaline bittrate Monohydrate (Levophed) L-(-)-Norinhrine (bittrate hydrate) L-terenol hydrogen L-ttrate 4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol 2,3-dihydroxysuccinate (1:1) L-(-)-NORINHRINE-(+)-BITTRATE L-NORADRENALINE BITTRATE //BP L-Norinhrine (+)-bittrate salt monohydrate L-(-) L-Norepinephrine Hydrogen L-Tartrate Monohydrate Noradrenaline bittrate(L-Noradrenaline bittrate monohydrate) ) (R)-(-Norinhrine L-bittrate monohydrate R(-)-4-(2-AMINO-1-HYDROXYETHYL)-1,2-BENZENEDIOL-(+)-TTRATE Norinhrine bittrate hydrate Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with 4-[(1R)-2-amino-1-hydroxyethyl]-1,2-benzenediol (1:1) L-(-)-Norepinephrine (+)-bitartrate salt monohydrate Norepinephrine (bitartrate monohydrate) inhrine Impurity 28 L-Noradrenaline Bittrate Monohydrate> NORINHRINE BITTRATE MONOHYDRATE*20 0 MG PER VI L-4-(A-HYDROXY-B-AMINOETHYL)CATECHOL BITTRATE 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-,(2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate Levoterenol Bittrate Monohydrate (S)-2-amino-1-(4-methoxyphenyl)ethan-1-ol (R)-(-)-NORINHRINE L-BITTRATE & norinhrine hydrogen ttrate monohydrate L-terenol Bittrate L-Norinhrine Bittrate 1,2-Benzenediol, 4-[(1R)-2-amino-1-hydroxyethyl]-, (2R,3R)-2,3-dihydroxybutanedioate, hydrate (1:1:1) L-Noradrenaline Bitartrate Monohydrate L-NORADRENALINE BITTRATE 108-0 Levterenol bittrate monohydrate L-(-)-Norinhrine monohydrate (+)-bittrate salt NORINHRINE BITTRATE Norinhrine (bittrate Monohydrate) L-terenol Bittrate Monohydrate Norinhrine bittrate monohydrate,Autophagy,Levterenol bittrate,Norinhrine bittrate,Beta Rector,L-Noradrenaline bittrate,Inhibitor,inhibit,Adrenergic Rector,Endogenous Metabolite 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol (L-(+))-bittrate salt 4-[(1R)-2-amino-1-hydroxyethyl]-1,2-Benzenediol (2R,3R)-2,3-dihydroxybutanedioate hydrate (1:1:1) L-Nradrenaline bittrate Noradrenaline bitartrate monohydrate L-Norinhrine bittrate hydride 4-(2-amino-1-hydroxyethyl)benzene-1,2-diol 2,3-dihydroxybutanedioate (1:1) L-Arterenol Bitartrate Monohydrate (2R,3R)-2,3-Dihydroxysuccinic acid - 4-[(1R)-2-amino-1-hydroxyethyl]-1,2-benzenediol (1:1) L-NORINHRINE BITTRATE L-TERENOL BITTRATE 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol Hydrogen Ttrate Monohydrate 4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol 2,3-dihydroxysuccinate (1:1) (R)-4-(2-amino-1-hydroxyethyl)benzene-1,2-diol (2R,3R)-2,3-dihydroxysuccinate hydrate (R)-(-)-norinhrine L-bittrate monohydrate L-Norepinephrine Bitartrate Monohydrate L-Norinhrine bittrate salt Noradrenaline ttrate CRS L- ()-Norinhrine (+)-bittrate salt monohydrate Norinhrine bittrate monohydrate, 10 mM in DMSO (-)-TERENOL BITTRATE SALT 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, 2,3-dihydroxybutanedioate (1:1) (salt) L-NORADRENALINE BITTRATE NORADRENALINE |
| Description | Norepinephrine bitartrate monohydrate is a β1-selective adrenergic receptor agonist with EC50 of 5.37 μM. |
|---|---|
| Related Catalog | |
| Target |
EC50: 5.37 μM (β1-selective adrenergic receptor)[1] |
| In Vitro | Norepinephrine(NE) bitartrate monohydrate is generally considered to be a β1-subtype selective adrenergic agonist. Norepinephrine(NE) also has direct activity at the β2-adrenoceptor in higher concentrations[1]. Adipocytes from the inguinal fat pad (iWA) or the interscapular fat pad (BA) are isolated from neonatal wild-type C57BL/6J mice and cultured. To examine the effect of activating AT2 upon β-adrenergic signaling, cAMP production is first assessed in response to Norepinephrine (NE, 10 µM) with or without CGP (10 nM) co-treatment. Norepinephrine (NE) increases cAMP as expected in iWA, and CGP does not alter this effect. Norepinephrine (NE) is also known to induce lipolysis, and liberated fatty acids are required to functionally activate UCP1 protein and to stimulate heat production. CREB phosphorylation at Ser133 is increased after Norepinephrine (NE) treatment and significantly attenuated with CGP co-treatment in mouse iWA[2]. |
| Cell Assay | Subcutaneous preadipocytes derived from a 38-year old non-diabetic female donor are immortalized with TERT and HPV E6/E7. For the current studies, a stable diploid clone (referred to as clone B) with consistent differentiation capacity is isolated by ring cloning. Cells are grown in preadipocyte PGM2 media. Once cells are confluent, differentiation is induced by incubation in differentiation media consisting of dexamethasone, IBMX, indomethacin, and additional insulin. Cells are differentiated for 10 days. Prior to treatment, media is replaced with PGM2 media for one day and then switched to serum-free media overnight for treatments. Adipocytes are treated for 6 hours with vehicle, Norepinephrine (NE, 10 μM), CGP (10 nM), or Norepinephrine (NE) and CGP[2]. |
| References |
| Boiling Point | 442.6ºC at 760mmHg |
|---|---|
| Melting Point | 100-104ºC(lit.) |
| Molecular Formula | C12H19NO10 |
| Molecular Weight | 337.28 |
| Flash Point | 221.5ºC |
| PSA | 201.77000 |
| Vapour Pressure | 1.3E-08mmHg at 25°C |
| Index of Refraction | -11 ° (C=5, H2O) |
| Storage condition | Refrigerator |
| Water Solubility | H2O: soluble50mg/mL, clear |
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H300 + H310 + H330 |
| Precautionary Statements | Missing Phrase - N15.00950417-P260-P262-P280-P302 + P352 + P310-P304 + P340 + P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | T+: Very toxic; |
| Risk Phrases | R26/27/28 |
| Safety Phrases | 22-26-36/37/39-45-36/37-28 |
| RIDADR | UN 2811 |
| WGK Germany | 3 |
| RTECS | DN6750000 |
| Packaging Group | III |
| HS Code | 2922210000 |
| HS Code | 2922509090 |
|---|---|
| Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |